Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Stärke
Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Packungsgröße
Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Form
Tafinlar-H-C-2604-PSUV-0005: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Nebenwirkungen
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.